跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAPAGLIFLOZINA TEVA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DAPAGLIFLOZINA TEVA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
DAPAGLIFLOZINA TEVA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Teva B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 9, 2022
Approval ID
9a64dae813d2e8a2
Company
Teva B.V.
Type
Standard
Approval Details
Approval Id
9a64dae813d2e8a2
Drug Cima Aemps Name
DAPAGLIFLOZINA TEVA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
88074
Holder Company Name
Teva B.V.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-pharma-b-v
Authorization Date
2022-09-09
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Teva B.V.
Company Detail Path
/organization/teva-pharma-b-v
Company Information
Pharmaceutical Company Name
Teva Pharma B.V.
Country Name
Netherlands
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Website
http://www.tevapharm.com
Active Ingredients
DAPAGLIFLOZINA
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 9, 2022
Approval ID
9a64dae813d2e8a2
Type
Standard
Back to CIMA-AEMPS Approvals